Establishment, characterization and drug sensitivity of four new human soft tissue sarcoma cell lines

International Journal of Cancer

Volumn 68, Issue 4, 1996, Pages 514-519

  Wei Wei, L I ^a   Cordon Cardo, Carlos ^a   Chen, Quanguang ^a   Jhanwar, Suresh C ^a   Bertino, Joseph R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; DOXORUBICIN; EDATREXATE; FLUOROURACIL; METHOTREXATE; PACLITAXEL; TRIMETREXATE; VINBLASTINE;

ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOGENETICS; DRUG SENSITIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; MORPHOLOGY; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; TUMOR CELL LINE;

ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; HUMANS; MICE; MICE, NUDE; SARCOMA; SOFT TISSUE NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 10544229344     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961115)68:4<514::AID-IJC18>3.0.CO;2-4     Document Type: Article

References (20)

1. CORDON-CARDO, C., FINSTAD, C.L., BANDER, N.H. and MELAMED, M.R., Immunoanatomical distribution of cytostructural and tissue-associated antigens in the human urinary tract. Amer. J. Pathol., 126, 269-284 (1987).
2. DENIS, N., KITZIS, A., KRUH, J., DAUTRY, F. and CORCOS, D., Stimulation of methotrexate resistance and dihydrofolate reductase gene amplification by c-myc. Oncogene, 6, 1453-1457 (1991).
3. GERLACH, J.H., BELL, D.R., KARAKOUSIS, C., SLOCUM, H.K., KARTNER, N., RUSTUM, Y.M., LING, V. and BAKER, R.M., P-glycoprotein in human sarcoma: evidence for multidrug resistance. J. clin. Oncol., 9, 1452-1460 (1987).
4. GRANA, X. and REDDY, E.P., Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinase CCDK's, growth suppressor genes and cyclin-dependent kinase inhibitors CCKI's. Oncogene, 11, 211-219 (1995).
5. GREENALL, M.J., MAGILL, G.B., DECOSSE, J.J. and BRENNAN, M.F., Chemotherapy for soft tissue sarcoma. Surg. Gynecol. Obstet., 62, 193-198 (1986).
6. HAMBURGER, A.W. and SALMON, S.E., Primary bioassay of human tumors stem cells. Science, 197, 461-463 (1977).
7. HELIN, K., HARLOW, E. and FATTAEY, A., Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. cell. Biol., 13, 6501-6508 (1993).
8. JOHNSON, D.G., CRESS, W.D., JAKOI, L. and NEVENS, J.R., Oncogenic capacity of the E2F1 gene. Proc. nat. Acad. Sci. (Wash.), 91, 12823-12827 (1994).
9. KAYE, S.B., Docetaxel (taxotere) in the treatment of solid tumors other than breast and lung cancer. Semin. Oncol., 22 (Suppl. 4), 30-33 (1995).
10. LI, W.W., FAN, J., HOCHHAUSER, D., BANERJEE, D., ZIELINSKI, Z., ALMASAN, A., YIN, Y., KELLY, R., WAHL, G.M. and BERTINO, J.R., Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines. Proc. nat. Acad. Sci. (Wash.), 92, 10400-10436 (1995).
11. LI, W.W., LIN, J.T., SCHWEITZER, B.I., TONG, W.P., NIEDZWIECKI, D. and BERTINO, J.R., Intrinsic resistance to methotrexate in human tissue sarcoma cell lines. Cancer Res., 52, 3908-3913 (1992).
12. wafl in NIH3T3 cells. Oncogene, 12, 775-784 (1996).
13. MITELMAN, F. (ed.), Guidelines for cancer cytogenetics. Supplement to an international system for cytogenetic nomenclature. Karger, Basel (1991).
14. NIIMI, S., NAKAGAWA, K., YOKOTA, J., TSUNOKAWA, Y., NISHIO, K., TERASHIMA, Y., SHIBURA, M., TERUDA, M. and SAIJO, N., Resistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-ras genes. Brit. J. Cancer, 63, 237-241 (1991).
15. ink4. Science, 267, 249-252 (1995).
16. 1 arrest involves pRb-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. nat. Acad. Sci. (Wash.), 91, 5320-5324 (1994).
17. SLOVAK, M.L., MICSKI, S.E.L., COLE, S.P.C., GERLACH, J.H., YOHEM, K.H. and TRENT, J.M., Tumorigenic multidrug-resistant HT 1080 cells do not overexpress receptors for epidermal growth factor. Brit. J. Cancer, 64, 296-298 (1991).
18. STRATTON, M.R., Moss, S., WARREN, W., PATTERSON, H., CLAR, J., FISHER, C., BALL, A., THOMAS, M., GUSTERSON, B.A. and COOPER, C.S., Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene. Oncogene, 5, 1297-1301 (1990).
19. TOGUCHIDA, J., YAMAFUCHI, T., RITCHIE, B., BEAUCHAMP, R.L., DAYTON, S.H., HERRERA, G.E., YAMAMURO, T., KOTOURA, Y., SASAKI, M.S., LITTLE, J.B., WEICHSELBAUM, R.R., ISHIZAKI, K. and YANDELL, D.W., Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res., 52, 6194-6199 (1992).
20. ZAMBETTI, G.P. and LEVINE, A.J., A comparison of the biological activities of wild-type and mutant p53. FASEB J., 7, 855-865 (1993).